This review is an update of key issues in gastric interventional endoscopy. It focuses on the areas of patient preparation, endoscopic mucosal resection, gastroduodenal stenting, and endoscopic placement of enteric feeding tubes. Recent findings Clopidogel (Plavix), a newer antiplatelet agent, can increase the risk of bleeding. Therefore, in selected cases, it should be held for 7--10 days prior to interventional procedures. In experienced hands, endoscopic mucosal resection (success rate, 76--100%; complication rate, 4--28%) and gastroduodenal stenting (success rate, 81--92%; complication rate, 1--17%) seem to be safe and effective techniques. Summary The field of interventional endoscopy continues to advance and to conquer new frontiers. These advances create new problems that need to be addressed and studied by researchers, however. It is only through these types of reviews that our state of knowledge can be updated to help provide the latest information for clinicians in the field and to challenge researchers with future problems that need to be studied.
Introduction
Interventional endoscopy is a field that continues to grow exponentially. Given the limited space that we have available for this review, we limit our update to three areas. We start with a discussion of patient preparation issues that need to be addressed prior to the performance of interventional procedures. This is followed by a review of proper techniques for the more advanced endoscopic procedures in the stomach. We conclude by exploring future directions in the field.
Patient preparation
Patient preparation is essential for safe interventional endoscopy and good outcome. Key elements are evaluating patients for potential risks of bleeding, determining the need for antibiotic prophylaxis, and providing proper sedation. If not properly addressed, each of these elements can lead to untoward complications in patients who are undergoing interventional endoscopy.
Evaluating patients for potential bleeding risks
All patients presenting for interventional endoscopy need to have their coagulation factors (prothrombin time/partial thromboplastin time) checked and corrected. Studies have shown that patients with coagulopathies who undergo interventional procedures are at increased risk for bleeding. In a retrospective review of patients after polypectomy (n = 1657), coagulopathic patients on warfarin were found to be at increased risk of bleeding after procedure (odds ratio, 13.37; 95% confidence interval, 4.10-43.65) [1 •• ]. In the same study, non-steroidal anti-inflammatory drugs use did not seem to be associated with any such risk and would therefore not require any preprocedure preparation. Data seem to indicate, however, that clopidogrel, a newer antiplatelet agent shown to prevent ischemic events, can be associated with increased risk of bleeding. In a recent study, where patients with healed bleeding gastric ulcers were randomized to receive either clopidogrel or aspirin plus esomeprazole, those receiving clopidogrel had a significantly higher rate of bleeding (13/161) than those who were on the aspirin/ esomeprazole regimen (1/159; P = 0.001) [2 •• ]. As a result, the American Society of Gastrointestinal Endoscopy Standards of Practice committee has recently recommended that in high-risk procedures, clopidogrel and ticlopidine, an analogous antiplatelet agent, should be discontinued for 7-10 days prior to any interventional procedure [3 • ].
Determining the need for antibiotic prophylaxis for infective endocarditis
Antibiotic prophylaxis is another key component in the preparation of patients undergoing interventional endoscopy. Esophageal dilation and sclerotherapy are associated with a high incidence of transient bacteremia, 12-22% [4] . Although no studies to date have demonstrated that antibiotic prophylaxis reduces infective endocarditis during endoscopic procedures, it is generally recommended that patients with high risk conditions (e.g prosthetic valves, systemic-pulmonary shunts, synthetic vascular grafts less than one year old, complex cyanotic congenital heart disease, and a history of prior endocarditis) should receive antibiotic prophylaxis when undergoing high risk procedures (i.e. esophageal dilation, esophageal sclerotherapy, and endoscopic retrograde cholangiopancreatography of obstructed ducts). Prophylaxis is optional in patients with moderate risk conditions such as congenital or acquired valvular dysfunction, hypertrophic cardiomyopathy, and mitral valve prolapse with regurgitation when undergoing high risk endoscopic procedures. Antibiotic prophylaxis is not recommended for patients (1) with low risk conditions such as pacemakers, implantable defibrillators, and prosthetic joints or (2) undergoing low risk procedures such as esophagogastroduodenoscopy, esophageal variceal ligation, and colonoscopy with or without polypectomy. The recommended regimen for prophylaxis is amoxicillin 2.0 gm orally 1 hour prior to the procedure or intravenously 30 minutes prior to the procedure. Penicillin allergic patients should receive clindamycin 600 mg orally 1 hour prior to the procedure or intravenously within 30 min of the procedure [5] . Other suitable alternatives for penicillin allergic patients include cephalexin (2.0 gm), azithromycin or clarithromycin (500 mg), cefazolin (1.0 gm), or vancomycin (1.0 gm).
Providing proper sedation
Some patients may not require any type of intravenous sedation for their interventional endoscopic procedure. In one study, elderly patients with decreased pharyngeal sensation tolerated their procedures well without any type of sedation [6] . In another study, the use of orally administered premedication seemed to decrease anxiety levels and prevent the need for any intravenous sedation altogether [7 •• ]. Most patients will need some type of intravenous sedation, however. Although there is a great deal of variability, an appropriate level of sedation can be reached for most patients through the use of a benzodiazepine combined with a narcotic [8 • ]. The benzodiazepine provides an amnesic effect while the narcotic provides an analgesic effect. Patients who receive mono-therapy (benzodiazepine only) have more severe pain (28% vs 9%; P < 0.001) and less procedure tolerance (18% vs 6%; P < 0.01) than those who receive the combination [9] . In selected patients, notably those with chronic narcotic, benzodiazepine, alcohol, or illicit drug use, the use of midazolam and benzodiazepines alone may be insufficient [10] .
When more sedation is needed, the patient is said to require deep sedation. This can be accomplished through general anesthesia or the addition of a third agent (droperidol or propofol) to the benzodiazepine-narcotic combination set previously described [11 • ].
Droperidol
Droperidol is a neuroleptic agent, in the same class as haloperidol, with sedative effects that potentiate the actions of benzodiazepines and narcotics [11 • ].
Propofol
Propofol is an ultra-short-acting hypnotic agent that provides amnesia but minimal levels of analgesia [12] . Studies have shown that it can also interfere with cortical processes necessary for normal memory functions [13] .
Of the two agents, propofol seems to be the agent of choice for safe deep sedation in most patients. A review of the literature demonstrates that the complication rate, as defined by hypoxia and/or hypotension, ranges between 0.0-17.1%, with a mean value of 2.4% (Table 1) [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] . These values seem to be well within the range found in a comparable group of patients who underwent standard sedation, where the complication rate was 0-17.8%, with [29, 30] . Until more data are available, however, the routine use of these more sensitive monitors cannot yet be recommended.
Techniques
Careful attention to technique is crucial to ensure excellent procedural outcome. In this section, we provide the proper techniques for three of the more advanced endoscopic procedures performed in the stomach: endoscopic mucosal resection, gastroduodenal stenting, and placement of enteric feeding tubes. For those interested in a discussion of hemostasis, please refer to last year's review.
Endoscopic mucosal resection
Endoscopic mucosal resection (EMR) is an advanced technique that involves the endoscopic removal of significant amounts of mucosal/submucosal tissue [31] . One of its major indications is tissue acquisition for diagnosis of subepithelial lesions and hypertrophic gastric folds. Its second major indication is curative resection of early gastric cancer. When used for curative resection, imaging studies should be performed beforehand to ensure the presence of a superficial cancer (<500 um) and the absence of any lymphadenopathy because patients with deep cancers and those with lymphadenopathy will not benefit from this technique [32] . Of the currently available imaging modalities, endoscopic ultrasound seems to be the most useful. In a prospective randomized study of 88 patients with gastric cancer, endoscopic ultrasound was able to stage the depth of tumor penetration and the presence of lymphadenopathy correctly in 63% of cases, compared with 44% for spiral computed tomography (CT) (P < 0.021) [33] .
The following steps are key for the safe and effective performance of endoscopic mucosal resection: adequate identification of the lesion, proper marking of the lesion, appropriate elevation of the lesion with a fluid cushion, complete resection of the lesion, and closure of the mucosal defect, created by the procedure, if indicated [31] . 
Marking of the lesion
Once the target lesion is identified, it is best marked by placing spots, made electro-surgically, in the mucosa with a needle knife [39] .
Appropriate elevation of the lesion with a fluid cushion
Once the mucosal lesion is identified and marked, fluid is injected submucosally to separate it from the muscularis propria [31] . This fluid cushion provides protection against iatrogenic thermal injury and is considered to be the most important step in the successful and safe performance of this technique [40] . If the lesion cannot be raised by a fluid cushion, the procedure should not be performed.
A number of solutions have been used to form the fluid cushion, including saline, 20% dextrose, sodium hyaluronate, hydroxypropyl methylcellulose, and glycerol [41] [42] [43] [44] [45] . Although saline and hypertonic glucose have been used most commonly, they are short-lived, and reinjection during the procedure may be required. Sodium hyaluronate, glycerol, and hydroxypropyl methyl cellulose (artificial tears) may be better agents because they last longer. In a recent animal model study, normal saline was found to last a median of 2.4 minutes after injection; 50% dextrose, 4.7 minutes; glycerol, 4.2 minutes; sodium hyaluronate, 22.1 minutes; and hydroxypropyl methylcellulose, 36 minutes [41, 42] .
Complete resection of the lesion
A number of techniques have been described to resect the raised lesion. Of these, the most commonly used technique is the cap-assisted EMR [31] . This technique involves the placement of specially designed cap on the tip of the endoscope. Once the target lesion is identified, marked, and lifted, it is suctioned into the cap and resected using a prelooped crescent-shaped snare (SD-221L-25 or SD-7P-1; Olympus America, Inc, Melville, NY, USA).
Closure of the mucosal defect if indicated
Endoscopic mucosal resection-induced defects develop into ulcers. No data are currently available regarding their management. On the basis of consensus opinion, however, smaller defects will heal with omeprazole therapy and require no other intervention [46 • ]. On the other hand, larger defects will benefit from primary closure using mechanical approximation. One such closure technique has been described in a case report using a double channel endoscope, an endoloop, and hemoclips ( Fig. 1) Tables 2 and 3 ) [39, [49] [50] [51] [52] [53] .
All of the reported complications were minor episodes of bleeding that were treated endoscopically. No episodes were reported of severe complications in these series. Although these results emphasize the safety of this technique in experienced hands, one must be cautious because of publication bias and observer bias. It should be emphasized that none of the published series was randomized or blinded.
Gastroduodenal stenting
Gastroduodenal stenting is a technique used to palliate patients with malignant gastric outlet obstruction, usually the result of advanced pancreatic adenocarcinoma, ampullary adenocarcinoma, or duodenal adenocarcinoma [54] . The biliary tract is often concomitantly obstructed, so consensus opinion suggests that the patency of the biliary tract should be assessed prior to placement of the gastroduodenal stent. If the biliary tract is occluded, it should be stented first prior to placement of the gastroduodenal stent. If the biliary tract is patent, then only the gastroduodenal stent needs to be placed.
A number of self-expanding metal stents are currently available for use. They include Wallstent (Microvasive, Natick, MA, USA), Z-stent (Wilson-Cook Medical, Winston-Salem, NC, USA), and Esophacoil (Instent, Minneapolis, MN, USA) [55, 56] . Of these, the only selfexpanding metal stent that is approved for use in gastroduodenal obstruction is the enteral Wallstent (length, 60 and 90 mm; diameter, 18, 20, and 22 mm). Recently, a new prosthesis has been introduced (Boubella FerX Ella; Volenec-Ella, Hradec Kralove, Czech Republic) [57] . It is a stainless steel stent covered by a poly-ethylene membrane with a proximal funnel attached to an expanding antimigratory segment 29 mm in diameter. Although it offers an interesting design that is thought to reduce the potential risk of migration, further testing will need to be performed before its routine use can be recommended.
An excellent technique for gastroduodenal stenting has been described in a recent review article [58] . It can be divided into five steps: passing the endoscope beyond the narrowed duodenal lumen, if possible; placing a hemoclip (or a submucosal injection) to mark the proximal and distal parts of the region that needs to be stented; threading a wire through the endoscope under fluoroscopic guidance to the distal duodenum beyond the area of narrowing; advancing the stent through the scope and over the wire beyond the narrowed region of the duodenum; and deploying the stent with endoscopic and fluoroscopic guidance.
With careful attention to technique, the results can be very good. Success rate is estimated to be 96.5% (251/260), with a complication rate of 9.2% (24/260; perforation. Once the stent is placed, the patient is encouraged to advance their diet as tolerated immediately.
To prevent stent occlusion, however, they are instructed to avoid leafy vegetables. Long-term follow-up of these patients is recommended to look for potential minor complications that can be corrected endoscopically such as stent migration, bleeding, stent occlusion, and biliary occlusion.
Placement of enteric feeding tubes
Placement of enteric devices for nutrition is a technique that is indicated in patients who have an intact, functional gastrointestinal tract but are unable to consume sufficient calories to meet their metabolic needs [63] . Candidates include patients with impaired swallowing caused by cerebrovascular accidents, neoplastic conditions (cancer of the esophagus, oropharynx, or larynx), and neurologic conditions [63, 64] . Patients with dementia should be excluded as studies have shown no improvement in nutritional status, quality of life, or survival in this group of patients [65] .
A number of enteral nutrition access devices are currently available [63] . These include nasoenteric feeding tubes (nasogastric and nasojejunal), percutaneous endoscopic gastrostomy tubes (PEGs), PEGs with jejunal extensions (PEG-Js), and direct percutaneous endoscopic jejunostomy tubes (D-PEJs). D-PEJs are a recent development in the field of enteral nutrition. Fan et al. [66] showed that over a 6-month period, 5 of 37 (13.5%) of the patients who received D-PEJ required reintervention because of luminal occlusion, compared with 19 of 34 (55.9%) who received PEG-J tubes (P < 0.000085). The type of tube to be chosen depends on two factors: the estimated duration of nutritional support, and the presence or absence of aspiration risk. If the nutritional support is estimated to be of short duration (less than 4 weeks), nasoenteric tubes are recommended. If the nutritional support is thought to be of long duration (greater than 4 weeks), however, percutaneous tubes are recommended. Patients at risk for aspiration should receive jejunal tubes (nasojejunal, PEG-J, or D-PEJ), and those who are not should receive gastric tubes (nasogastric or PEG). The placement technique will differ depending on the type of tube used.
Placement of nasoenteric tubes
In the past, the tubes were placed at the bedside without endoscopic guidance. Recent studies, however, demonstrate that the use an endoscope not only facilitates the placement of these tubes but also allows the identification of pathology (ulcers and tumors) that may potentially interfere with their use [67] . Therefore, endoscopic assistance is now recommended to place these tubes. This is best accomplished through a transnasal technique, using a small caliber endoscope. Studies have shown that such an approach requires less procedure time (8 minutes vs 12 minutes; P < 0.001), less sedation, and fewer cardiopulmonary side effects than the traditional transoral approach [68] .
Placement of percutaneous endoscopic gastrostomy tubes
The technique for PEG tube placement has been recently reviewed [67] . Key features of the technique are preprocedure prophylactic antibiotics to decrease the development of peristomal skin infections; identification of the best abdominal wall site for tube placement by finger palpation and transillumination; local sterilization and anesthetization of the chosen abdominal wall site; insertion of a trocar through the incision site, followed by a guide wire which is snared and pulled out of the mouth; and use of This is the number of successful complete endoscopic resection by EMR based on histology. Palliative resections, benign lesions and those performed for diagnostic purpose were not included in these calculations. [50] 101 Cap assisted with saline injection 0/101 (0%) 22/101 (21.7%) Yamamoto [51] 70 Cap assisted with sodium hyaluronate injection 0/70 (0%) 3/70 (4.2%) Okano [52] 477 Cap assisted with saline injection 0/477 (0%) 25/477 (2.5%) Total 675 0/675 (0%) 50/675 (7.4%) the pull or push technique to place the bumper at the desired location and securing it.
This technique, however, has limitations: it requires oral access, which can be difficult in patients with head and neck cancer; it requires close approximation of the stomach to the abdominal wall, which is impractical in patients with ascites; and it causes contamination of the PEG during its insertion as it passes through the oral cavity, predisposing patients to peristomal wound infection. A number of modifications have been suggested to overcome these limitations. In patients with head and neck cancer, for example, transnasal access can be used in place of the transoral route, with better outcome [69] . In patients with ascites, the technique becomes practical if one is able to first approximate the anterior gastric wall to the abdominal wall. This can be done by a recently described maneuver termed endoscopic gastropexy (Fig. 2) [70 • ]. Finally, in cases where the risk of peristomal infections is high, two alternative modifications to the technique have been described to avoid oral contamination of the PEG. One modification relies on the use of a special introducer kit. This modification avoids the oral contamination of the pull or push techniques and reduces the peristomal infection rate from nine of 30 to zero of 30 (P = 0.0094) [71] . The alternative modification simply relies on the use of an overtube to protect the PEG from oral contamination during the pull and push methodology. This modification is somewhat more cumbersome but just as successful in that it has been shown to reduce the rate of peristomal infection from 12 of 37 to two of 36 (P = 0.0029) [72 • ].
Placement of direct percutaneous endoscopic jejunostomy tubes
The technique for D-PEJ placement has been recently described using a pediatric colonoscope [73] . Once the jejunum is intubated, transillumination is attempted. Finger pressure is performed along with transillumination to confirm the presence of a safe site for the placement of the jejunal tube. Once the site is identified, it is prepped, draped, and anesthetized in the usual fashion. A sounding needle is used to perform the puncture. Once it enters the jejunum, it is grasped with a snare. A stylet-sheath is threaded over the needle into the small bowel. A wire is passed through the sheath. The snare grasps the wire and is pulled out with the scope through the mouth. The percutaneous endoscopic jejunostomy is secured to the wire, pulled in, and fastened to the abdominal wall in a manner analogous to that of PEG placement. Its safety approaches that of PEG placement.
No matter what type of enteric feeding device is placed, close follow-up is crucial to detect complications and identify patients who can be weaned from tube feedings. For instance, studies have shown that in patients with pharyngeal dysphagia secondary to abnormal upper esophageal sphincter opening, up to 20% of patients regain their ability to swallow and no longer need their feeding tube [74] . Furthermore, for those patients who continue to depend on their feeding tubes for nutrition, studies show that tube malfunction occurs in 8-33% of cases [75, 76] .
Future directions
Over the past few years, accessories and tools have been developed that allow the performance of more advanced procedures endoscopically. These include the placement of electric stimulation devices to improve stomach function in patients with gastroparesis, pyloromyotomy to improve gastric emptying in patients with congenital pyloric stenosis, and gastric stapling devices to control gastro-esophageal reflux symptoms endoscopically [77] [78] [79] . Recently, using the porcine animal model, studies have demonstrated that the stomach can be used as a gateway to the retroperitoneum, allowing the performance of a number of therapeutic procedures trans-gastrically (Fig. 3) [80, 81] . Access to the retroperitoneum is simple. Following stomach insufflation, a needle knife can be used to puncture the gastric wall. Balloon dilators can be used to extend the puncture and allow the passage of the endoscope into the retroperitoneum. Once access into the retroperitoneum has been gained, a number of therapeutic procedures can be successfully performed, including fallopian tube ligation, cholecystectomy, and appendectomy [80, 81] 
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